CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


This is an archived document. The links are no longer being updated.

TB Notes 2, 2001

New CDC Publications

Driscoll JR, Lee PA, Jovell RJ, Hale YM, Salfinger M. How and why we fingerprint tuberculosis. RT, The Journal for Respiratory Care Practitioners 2001;14(1).

Lan NTN, Iademarco MF, Binkin NJ, Tung LB, Quy HT, Co NV. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard re-treatment regimen in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2001;5(6):575-578.

Laserson KF, Kenyon AS, Layloff TA, Binkin NJ. Substandard tuberculosis drugs on the global market and their simple detection. Int J Tuberc Lung Dis 2001;5(5):448-454.

O’Brien RJ, Nunn PP. The need for new drugs against tuberculosis: obstacles, opportunities, and the next steps. Am J Respir Crit Care Med 2001; 162:1055-1058.



Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333